- When designing MGPTs, a proper gene vetting process may improve detection rates
- Rates of clinically significant findings of MGPTs tend to increase with inclusion of genes with higher clinical validity scores
- VUS rates of MGPTs tend to increase with inclusion of genes with limited clinical validity without increasing the mutation rate